An Evaluation of Blood Glucose Levels and Insulin Requirement After Subacromial Corticosteroid Injection in Insulin Dependent Diabetics

Not Applicable

Withdrawn

• Conditions: Shoulder Injury; Insulin-dependent Diabetics
• Interventions: Other: Placebo; Drug: Dexamethasone

• Registration Number: NCT03328975
• Lead Sponsor: University of Pittsburgh

Brief Summary

The overall purpose of this study is to evaluate the effect of a corticosteroid shoulder injection on glucose levels in insulin-dependent diabetic men and women.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2017-09-17
• Status Verified: 2017-10
• Study First Submitted QC: 2017-10-29
• Last Update Submitted: 2017-10-29
• Study Start: 2017-11-01
• Study First Posted: 2017-11-01
• Last Update Posted: 2017-11-01
• Primary Completion: 2021-11-01
• Study Completion: 2022-11-01

Recruitment & Eligibility

• Status: WITHDRAWN
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

Not provided

Read More

Exclusion Criteria

Not provided

Read More

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Placebo	Placebo	Group 2 will receive an injection of 5 mL of 1% lidocaine (placebo).
Dexamethasone	Dexamethasone	Group 1 will receive an injection of 4mg of dexamethasone 4 mL of 1% lidocaine.

Primary Outcome Measures

Name	Time	Method
Can diabetic patients maintain their blood glucose in a normal range after receiving a corticosteroid injection?	4 weeks	The main outcome variable in this study is to determine what effects, if any, a corticosteroid injection has on the ability of diabetic patients to maintain their blood glucose in a normal range. This will allow for better patient education when discussing the risks of corticosteroid injections and allow for improved post-injection care of patients.